Opening book details…
Can I read Serotonin–dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias on EtoBox?
Serotonin–dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias by M CARTA; T CARLSSON; A MUNOZ; D KIRIK; A BJORKLUND is a book available to read on EtoBox.
What is Serotonin–dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias about?
Appearance of dyskinesia is a common problem of long-term Levodopa (L-DOPA) treatment in Parkinson's disease (PD) patients and represents a major limitation for the pharmacological management of the motor symptoms in the advanced stages of disease. An increasing body of evidence points to dopamine released as a false neurotransmitter from the striatal serotonin terminals as the main pre-synaptic determinant of L-DOPA-induced dyskinesia. Here we review the animal experimental and human clinical data in support of this view, which point to the serotonin system as a promising target for anti-dyskinetic therapy in PD patients under L-DOPA medication.
- Author
- M CARTA; T CARLSSON; A MUNOZ; D KIRIK; A BJORKLUND
- Publisher
- Elsevier
- Published
- 2008
- Language
- EN
More by M CARTA; T CARLSSON; A MUNOZ; D KIRIK; A BJORKLUND
Browse all works by M CARTA; T CARLSSON; A MUNOZ; D KIRIK; A BJORKLUND
Similar books
- Parkinson's Treatment in Perspective. Commentary on Levodopa and Dopamine Agonists in the Treatment of Parkinson's Disease by Theodore L. Sourkes and Serge Gauthier — Wolfgang Jost; Peter Riederer (2023)
- Dopamine Agonists in Treatment of Parkinson's Disease: an Overview — Dan Luo; Maarten Reith; Aloke K. Dutta (2020)
- Old and New Dopamine Agonists in Parkinson's Disease — Ubaldo Bonuccelli; International Congress on Dopamine Agonists. (1995)
- Parkinson-specific Motor and Mental Disorders Role of the Pallidum ; Pathophysiological, Biochemical, and Therapeutic Aspects — R. G Hassler; J. F Christ; International Symposium on Parkinson's Disease (1984)
- Phase I/II Trial of iPS-cell-derived Dopaminergic Cells for Parkinson’s Disease — Nobukatsu Sawamoto1,8, Daisuke Doi2,8, Etsuro Nakanishi1,8, Masanori Sawamura1,8, (2025)
- Management of Brittle Dyskinesia and Dopamine Dysregulation Syndrome in Subthalamic Deep Brain Stimulation — Junaid Siddiqui; Raja Mehanna; Jawad A. Bajwa (2020)